广州燃石医学检验所有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test 2023-01-03 22:24
Burning Rock Presents Latest Clinical Data from THUNDER Study at 2022 ASCO Annual Meeting 2022-06-15 20:01
Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detection Blood Test Kit 2022-06-01 19:49
Burning Rock Dx Launches Magnis BR to Innovate Total Process Automation for NGS Testing 2019-11-19 21:00
Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand 2019-02-14 14:33
1